Statement Of Cash Flows

KYORIN Pharmaceutical Co., Ltd. - Filing #7257328

Concept	As at 2025-03-31	2024-04-01 to 2025-03-31	2023-04-01 to 2024-03-31	As at 2024-03-31	As at 2023-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal	—	4,824,000,000 JPY	4,695,000,000 JPY	—	—
Interest and dividends received	—	505,000,000 JPY	501,000,000 JPY	—	—
Income taxes paid	—	-1,317,000,000 JPY	-2,975,000,000 JPY	—	—
Interest paid	—	-173,000,000 JPY	-66,000,000 JPY	—	—
Net cash provided by (used in) operating activities	—	3,506,000,000 JPY	1,549,000,000 JPY	—	—
Cash flows from operating activities
Cash flows from operating activities
Cash flows from facilities maintenance and investing activities
Purchase of property, plant and equipment	—	-5,697,000,000 JPY	-5,778,000,000 JPY	—	—
Proceeds from sale of property, plant and equipment	—	42,000,000 JPY	0 JPY	—	—
Purchase of investment securities	—	-152,000,000 JPY	0 JPY	—	—
Other, net	—	-122,000,000 JPY	-509,000,000 JPY	—	—
Cash flows from investing activities
Net cash provided by (used in) investing activities	—	-6,323,000,000 JPY	-3,187,000,000 JPY	—	—
Cash flows from financing activities
Dividends paid	—	-3,015,000,000 JPY	-3,013,000,000 JPY	—	—
Proceeds from long-term borrowings	—	20,000,000,000 JPY	JPY	—	—
Net cash provided by (used in) financing activities	—	3,952,000,000 JPY	-3,347,000,000 JPY	—	—
Repayments of long-term borrowings	—	-10,200,000,000 JPY	-200,000,000 JPY	—	—
Effect of exchange rate change on cash and cash equivalents	—	0 JPY	87,000,000 JPY	—	—
Net increase (decrease) in cash and cash equivalents	—	1,135,000,000 JPY	-4,897,000,000 JPY	—	—
Cash and cash equivalents	15,021,000,000 JPY	—	—	13,886,000,000 JPY	18,816,000,000 JPY